Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
09/2000
09/14/2000WO2000053573A1 Medicinal compositions with [2.2.1] and [3.1.1] bicycloskeleton antagonistic to both of pgd2/txa2 receptors
09/14/2000WO2000031074A3 Indole derivatives and their use as serotonin receptor ligands
09/14/2000WO1999063999A8 H1-histamine receptor antagonists
09/14/2000CA2366612A1 Pesticidal hetero-substituted oxadiazine compounds
09/14/2000CA2366607A1 Thiazolyl urea derivatives and their utilization as antiviral agents
09/14/2000CA2366260A1 Heterocyclic compounds having effect of activating .alpha.4.beta.2 nicotinic acetylcholine receptors
09/13/2000EP1034176A1 Thiophene-sulfonamide compounds
09/13/2000EP1034175A1 Substituted phenyloxazolidinones and their use as antibiotics
09/13/2000EP1034170A1 2-substituted 1,2-benzisothiazole derivatives and their use as serotonin antagonists (5-ht1a, 5-ht1b and 5-ht1d)
09/13/2000EP0915858B1 Intermediates for the preparation of 2-imidazoline-5-ones
09/13/2000EP0691962B1 1-amino-3-phenoxy propane derivatives as modulators of multi-drug resistance
09/13/2000CN1266431A Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists
09/13/2000CN1266428A Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same
09/13/2000CN1056372C Thiazolidinedione derivatives, their production and use
09/13/2000CN1056369C Pyridazinone derivatives or their salts, processes of their production, and anti-shock agents containing them
09/12/2000US6118007 Preparation process of nitroguanidine derivatives
09/12/2000US6117893 Heterocyclic compounds having anti-diabetic activity and their use
09/12/2000US6117883 Useful for modulating a muscarinic receptor.
09/12/2000US6117867 In medicine and veterinary medicine
09/12/2000US6117822 Substituted phthalimidocinnamic acid derivatives and intermediates for their preparation
09/12/2000CA2105384C Treatment of addiction to drugs and substances of abuse
09/12/2000CA2047773C Derivatives of benzofuran, benzothiophene, indole and indolizine, process for their preparation as well as the compositions containing them
09/08/2000WO2000052007A1 4-heterocyclysulfonamidyl-6-methoxy-5-(2-methoxy-phenoxy)-2-pyridyl-pyrimidine derivatives, their preparation and use as endothelin receptor antagonists
09/08/2000WO2000051999A1 New diazole derivatives as serotonergic agents
09/08/2000WO2000051997A1 Polycyclic thiazole systems and their utilization as anorectics
09/08/2000WO2000051986A1 Cyclopentanone dihydropyridine compounds useful as potassium channel openers
09/08/2000WO2000051608A1 3-thienyl and 3-furanyl pyrrolidine modulators of chemokine receptor activity
09/08/2000WO2000051602A1 Utilization of polycyclic 2-amino-thiazole systems in the production of medicaments for prophylaxis or treatment of obesity
09/08/2000WO2000027341A3 Novel method of treatment
09/08/2000CA2364903A1 Polycyclic thiazole systems and their utilization as anorectics
09/08/2000CA2362554A1 Utilization of polycyclic 2-amino-thiazole systems in the production of medicaments for prophylaxis or treatment of obesity
09/08/2000CA2361179A1 New diazole derivatives as serotonergic agents
09/08/2000CA2330541A1 Cyclopentanone dihydropyridine compounds useful as potassium channel openers
09/06/2000EP1032561A1 Substituted oximes as neurokinin antagonists
09/06/2000EP1032424A1 Combination of an aldose reductase inhibitor and a glycogen phosphorylase inhibitor
09/06/2000EP1032393A1 QUINOLINE-CONTAINING $g(a)-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS
09/06/2000EP0649843B1 Thiazoline derivative
09/06/2000CN1265669A Compounds which inhibit leukocyte adhesion mediated by VLA-4
09/06/2000CN1265660A 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1H-indole derivatives
09/06/2000CN1265658A 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutic application
09/06/2000CN1265652A 2-acrylaminopropanamines as tachykinin receptor antagonists
09/06/2000CN1265394A Compound as intermediates for use in preparation of optically active 2-imidazoline-5-one or 2-imidazoline-5-thionone derivatives
09/06/2000CN1056144C New use of 6-heterocyclic-4-amino-3,4,5-tetrahydrobenz (CD) indoles compound
09/05/2000US6114532 Anticoagulant
09/05/2000US6114526 Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
09/05/2000US6114374 2-and 2,5-substituted phenylketoenols
09/05/2000US6114365 Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents
09/05/2000US6114328 Isoxazoline and isoxazole fibrogen receptor antagonists
09/05/2000US6114322 Anticholesterol agent
08/2000
08/31/2000WO2000050423A1 C-21 modified epothilones
08/31/2000WO2000050414A1 Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical composition containing them
08/31/2000WO2000050405A1 Quinoline derivatives as tyrosine kinase inhibitors
08/31/2000WO2000050402A1 Pde iv inhibiting compounds, compositions and methods of treatment
08/31/2000WO2000050397A1 Substituted piperidinedione derivatives and herbicide
08/31/2000WO2000050390A1 N-substituted arylsulfonylamino hydroxamic acids useful as inhibitors of c-proteinase and for treating or preventing disorders related to unregulated collagen production
08/31/2000WO2000040558A8 Aspartic protease inhibitors
08/31/2000DE19908537A1 Verwendung von polycyclischen 2-Amino-Thiazol Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas Use of 2-amino-thiazole polycyclic systems for the production of medicaments for the prophylaxis or treatment of obesity
08/31/2000DE19908533A1 Polycyclische Thiazol-Systeme, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend diese Verbindungen Polycyclic thiazole systems, processes for their preparation and pharmaceutical compositions containing these compounds
08/31/2000CA2365793A1 Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical composition containing them
08/31/2000CA2364804A1 N-substituted arylsulfonylamino hydroxamic acids useful as inhibitors of c-proteinase and for treating or preventing disorders related to unregulated collagen production
08/31/2000CA2364653A1 Pde iv inhibiting compounds, compositions and methods of treatment
08/30/2000EP1031572A1 Pyridylpyrrole derivatives
08/30/2000EP1030840A1 Cyclic amine derivatives and their use as drugs
08/30/2000EP1030835A2 Urea derivatives and their use as integrin inhibitors
08/30/2000CN1265102A Benzothia (oxa) diazol derivatives and their use as endothelin-receptor antagonists
08/30/2000CN1265101A Crystalline dibentothiazepine derivatives and its use as antipsychotic agent
08/30/2000CN1265033A Certain diarylimidaozle derivatives, new class of NPY speific ligands
08/30/2000CN1055924C Novel aminoalkyl benzoxazolinones and benzothizolinones and pharmaceutical compsns. and method for preparing same
08/29/2000US6111110 Synthesis of benzo[f]quinolinones
08/29/2000US6111105 Chemical intermediates for ziprasidone, a neuroleptic agent; reacting a 2-(piperidino) or (1,2-benzisoxazol-3-yl) or (2-cyanophenyl)thio),3-cyanobenzene with piperazine at a temperature from 80-170 degrees c.
08/29/2000US6110963 Aryl-oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
08/29/2000US6110948 Treating of malignant tumor, tuberculosis, diabetes, blood dyscrasia, endocrine disease, infectious disease, or acquired immunodeficiency syndrome
08/29/2000US6110939 As a substance p antagonists treating tachykinin-mediated disease, asthma, central nervous system disorder
08/29/2000US6110938 1-(arylthioalkyl, arylaminoalkyl or arylmethylenealkyl)-4-(heteroaryl)piperidines and related compounds useful as antipsychotics and analgesics
08/29/2000US6110935 A promoter for n-methyl-d-aspartic acid (nmda) receptors, useful for such therapeutic purposes as facilitating the learning of behaviors, treating schizophrenia, memory impairment
08/29/2000US6110922 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
08/29/2000US6110918 Mesylate trihydrate salt of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihy dro-2(1H)-indol-2-one (=ziprasidone), its preparation and its use as dopamine D2 antagonist
08/29/2000US6110872 2,4,5-trisubstituted phenylketo-enols for use as pesticides and herbicides
08/29/2000CA2100099C Isothiazole derivatives and processes for preparing the same as well as termite controlling agents comprising the same as active ingredient
08/24/2000WO2000049021A2 16-halogen-epothilone derivatives, method for producing them and their pharmaceutical use
08/24/2000WO2000049020A2 Novel epothilon derivatives, method for the production thereof and their pharmaceutical application
08/24/2000WO2000049019A2 Novel epothilone derivatives, method for producing them and their pharmaceutical use
08/24/2000WO2000049017A1 1-((indoly azacycloalkyl) alkyl)-2,1, 3-benzothiadiazole 2,2-dioxides exhibiting 5-ht2a receptor activity
08/24/2000WO2000049016A1 Process for the preparation of 6-(perfluoroalkyl)uracil compounds
08/24/2000WO2000049015A1 Pyridine compounds and their pharmaceutical use
08/24/2000WO2000049007A1 Acetamido acetonitrile derivatives as inhibitors of cathepsin l and/or cathepsin s
08/24/2000WO2000049004A1 Process for the preparation of 6-(perfluoroalkyl) uracil compounds from urea compounds
08/24/2000WO2000049003A1 Process for the preparation of 6-(perfluoroalkyl)uracil compounds from carbamate compounds
08/24/2000WO2000049002A1 Processes and intermediates for the preparation of 1,3-oxazin-6-ones and uracils
08/24/2000DE19908765A1 New, chemically and metabolically stable 16-halo or cyano-epothilone derivatives are cell division regulators useful e.g. for treating malignant tumors or chronic inflammatory disease
08/24/2000DE19908763A1 New, chemically and metabolically stable benzo-fused epothilon derivatives, useful e.g. for treating malignant tumors or chronic inflammatory disease, are cell division regulators
08/24/2000DE19908760A1 New, chemically and metabolically stable epothilon derivatives having modified macrocyclic ring, useful e.g. for treating malignant tumors or chronic inflammatory disease, are cell division regulators
08/24/2000DE19907588A1 New C-21 modified epothilone derivatives useful for treating e.g. cancer and other proliferative diseases and inhibiting angiogenesis and inducing apoptosis
08/24/2000CA2364281A1 Processes and intermediates for the preparation of 1,3-oxazin-6-ones and uracils
08/24/2000CA2363000A1 Process for the preparation of 6-(perfluoroalkyl) uracil compounds from urea compounds
08/24/2000CA2362996A1 Process for the preparation of 6-(perfluoroalkyl)uracil compounds from carbamate compounds
08/24/2000CA2362990A1 Process for the preparation of 6-(perfluoroalkyl)uracil compounds
08/24/2000CA2361278A1 16-halogen-epothilone derivatives, method for producing them and their pharmaceutical use
08/23/2000EP1029861A1 Benzisothiazol-piperazinyl derivative and its use as neuroleptic
08/23/2000EP1029853A1 Heteroaromatic bicyclic derivatives useful as anticancer agents
1 ... 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 ... 628